Ecolab Inc. vs Linde plc — Stock Comparison
Q·Score Breakdown
6.8
Hold
Overall
7
Buy
Quality
Health
Growth
Valuation
Sentiment
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
LIN
High-quality business with 18% return on equity and 20% profit margins.
⚠ valuation offers limited margin of safety.
Analyst Consensus
BUY
Target $317.48 (+21.7%)
21 analysts
BUY
Target $525.49 (+4.0%)
25 analysts
Fundamentals
ECL
LIN
35.8×
Trailing P/E
34.6×
27.2×
Forward P/E
25.9×
12.8%
Profit Margin
20.3%
44.4%
Gross Margin
48.8%
22.4%
ROE
17.8%
10.0%
Revenue Growth
5.8%
7.8%
Earnings Growth
-9.4%
1.02
Beta
0.79
—
Price / Book
—
$73.7B
Market Cap
$234.1B
$249 – $309
52-Week Range
$388 – $516
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.